Svitlana Garbuzova-Davis

Title: **Svitlana Garbuzova-Davis: Innovator in Neurodegenerative Disorder Treatments**

Introduction

Svitlana Garbuzova-Davis is a distinguished inventor based in Tampa, FL, who has made significant contributions to the field of neurodegenerative disorder treatments. With a portfolio of six patents, her innovative work continues to push the boundaries of medical science, particularly in the utilization of human umbilical cord blood plasma for therapeutic purposes.

Latest Patents

Among her latest patents, Svitlana developed a groundbreaking method of using plasma derived from human umbilical cord blood (hUCB) to treat neurodegenerative diseases. This innovative treatment has shown promising results in modulating cell response and reducing apoptosis in patients with amyotrophic lateral sclerosis (ALS). Her research indicates that hUCB plasma not only attenuates hyperactive responses in ALS patients but also enhances the normal responses, thereby suggesting its potential as a standalone or supplementary therapeutic option in treating these debilitating conditions.

Career Highlights

Svitlana has worked with reputable institutions such as the University of South Florida and Saneron Cell Therapeutics, Inc. She has dedicated her research to exploring novel ways to harness the therapeutic properties of hUCB plasma, marking her as a trailblazer in her field. Her innovative approaches in research signify a commitment to improving outcomes for individuals suffering from neurodegenerative disorders.

Collaborations

Throughout her career, Svitlana has collaborated with esteemed colleagues, including Paul R. Sanberg and Jared Carl Ehrhart. These partnerships have contributed to her success in the lab and have resulted in advancements in the understanding and treatment of neurodegenerative diseases.

Conclusion

Svitlana Garbuzova-Davis stands out as an inspirational inventor whose work is transforming the landscape of neurodegenerative disorder treatments. Through her innovative patents and collaborative efforts, she continues to pave the way for new therapeutic strategies, ultimately aiming to enhance the quality of life for patients. Her dedication to research and innovation is commendable, and it positions her as a significant figure in the scientific community.